Akebia Therapeutics, Inc. ($AKBA)
Filing Information
| Accession Number | 0001591467-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
516,555
Total Value
$721,516.45
P&L
-0.7% ($1,752.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 2, 2026 | Sale | 46,660 | $1.39 | $64,857.40 | 3,417,189 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 2, 2026 | Sale | 96,065 | $1.39 | $133,530.35 | 3,321,124 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 2, 2026 | Sale | 114,891 | $1.39 | $159,698.49 | 3,206,233 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 2, 2026 | Grant/Award | 175,250 | $1.41 | $247,102.50 | 3,381,483 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 2, 2026 | Sale | 83,689 | $1.39 | $116,327.71 | 3,297,794 | Direct | โ | View Details |